Katrin Roth

ORCID: 0000-0002-3144-1162 · 3 papers in corpus
rct 2024
BMC women's health ·doi:10.1186/s12905-024-03188-8

BACKGROUND: The SCHUMANN study evaluated the efficacy and safety of the selective P2 × 3 antagonist eliapixant in patients with endometriosis-associated pelvic pain (EAPP). METHODS: SCHUMANN was a randomized, placebo- and active comparator…

lab-animal 2018
Contraception ·doi:10.1016/j.contraception.2018.08.001

OBJECTIVE: To compare the effects of chlormadinone acetate (CMA), dienogest (DNG) and drospirenone (DRSP) on prostaglandin biosynthesis in a human endometrial explants model. STUDY DESIGN: Human endometrial explants obtained by aspiration …

lab-animal 2018
·doi:10.1055/s-0038-1671290

To compare the effects of chlormadinone acetate (CMA), dienogest (DNG) and drospirenone (DRSP) on prostaglandin biosynthesis in a human endometrial explants model.